Literature DB >> 8542317

Antisense oligodeoxynucleotides against mu- or kappa-opioid receptors block agonist-induced body temperature changes in rats.

X H Chen1, E B Geller, J K de Riel, L Y Liu-Chen, M W Adler.   

Abstract

PL017 and dynorphin A1-17 were shown previously to cause a marked increase and a profound decrease in body temperature (Tb), respectively. In this study, we examined whether an antisense (AS) oligodeoxynucleotide (oligo) against cloned mu or kappa opioid receptors could block PL017- or dynorphin A-induced body temperature changes. Treatment with an AS oligo against mu receptors, but not sense (S) oligo, missense (MS) oligo or artificial cerebrospinal fluid (aCSF), abolished PL017-induced hyperthermia. In addition, treatment with an AS oligo against kappa receptors, but not S oligo, MS oligo or aCSF, greatly attenuated dynorphin A-induced hypothermia. This study further supports the notion that mu and kappa receptors mediate Tb regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8542317     DOI: 10.1016/0006-8993(95)00564-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo.

Authors:  X H Chen; L Y Liu-Chen; R J Tallarida; E B Geller; J K de Riel; M W Adler
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

Review 2.  Effects of opioids, cannabinoids, and vanilloids on body temperature.

Authors:  Scott M Rawls; Khalid Benamar
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.